Clinical Trials Browser

OTHER × Breast Neoplasms × zirconium-89-trastuzumab × Clear all

NCT01565200 2025-03-31

ZEPHIR

Phase 2 Completed

Breast Neoplasms

NCT01832051 2015-11-05

Clinical Value of 89Zr-trastuzumab PET

Phase 2 Completed

Breast Neoplasms

NCT01081600 2013-05-14

AUY922

Breast Neoplasms